No results... Try to modify Your query or/and modify or reset the filters.
Most cited article - PubMed ID 26318384
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy
Annals of the rheumatic diseases.
2017 Jan ;
76 (1) :
58-64.
[epub] 20150828
